Insiders · OKYO

OKYO insider transactions

OKYO Pharma Limited (OKYO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for OKYO

• 18d
  Amendment: CHIEF DEVELOPMENT OFFICER Jacob Gary S bought $4,900 worth of shares (3,500 units at $1.40), increasing direct ownership by 3% to 112,420 units (SEC Form 4)

  4/A - OKYO Pharma Ltd (0001849296) (Issuer)
• 18d
  Amendment: CHIEF EXECUTIVE OFFICER Dempsey Robert John bought $23,085 worth of shares (15,000 units at $1.54) (SEC Form 4)

  4/A - OKYO Pharma Ltd (0001849296) (Issuer)
• 18d
  Amendment: Director Brancaccio John P bought $7,385 worth of shares (5,000 units at $1.48), increasing direct ownership by 17% to 35,201 units (SEC Form 4)

  4/A - OKYO Pharma Ltd (0001849296) (Issuer)
• 18d
  Amendment: Chief Scientific Officer Patil Rajkumar V. bought $5,011 worth of shares (3,363 units at $1.49), increasing direct ownership by 20% to 20,030 units (SEC Form 4)

  4/A - OKYO Pharma Ltd (0001849296) (Issuer)
• 18d
  Amendment: Director Cerrone Gabriele M bought $35,000 worth of shares (25,000 units at $1.40) (SEC Form 4)

  4/A - OKYO Pharma Ltd (0001849296) (Issuer)
• 18d
  Amendment: Director Cerrone Gabriele M bought $32,625 worth of shares (22,500 units at $1.45) (SEC Form 4)

  4/A - OKYO Pharma Ltd (0001849296) (Issuer)
• 18d
  Amendment: CHIEF MEDICAL OFFICER Mantelli Flavio bought $28,000 worth of shares (20,000 units at $1.40) (SEC Form 4)

  4/A - OKYO Pharma Ltd (0001849296) (Issuer)
• 27d
  Chief Scientific Officer Patil Rajkumar V. was granted 3,363 shares, increasing direct ownership by 20% to 20,030 units (SEC Form 4)

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 27d
  New insider Patil Rajkumar V. claimed ownership of 16,667 shares (SEC Form 3)

  3 - OKYO Pharma Ltd (0001849296) (Issuer)
• 33d
  CHIEF EXECUTIVE OFFICER Dempsey Robert John was granted 15,000 shares (SEC Form 4)

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 33d
  Director Brancaccio John P was granted 5,000 shares, increasing direct ownership by 17% to 35,201 units (SEC Form 4)

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 33d
  Director Cerrone Gabriele M was granted 22,500 shares (SEC Form 4)

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 33d
  CHIEF DEVELOPMENT OFFICER Jacob Gary S was granted 3,500 shares, increasing direct ownership by 3% to 112,420 units (SEC Form 4)

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 34d
  CHIEF MEDICAL OFFICER Mantelli Flavio was granted 20,000 shares (SEC Form 4)

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 35d
  Director Cerrone Gabriele M was granted 25,000 shares (SEC Form 4)

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 69d
  SEC Form 3 filed by new insider Mantelli Flavio

  3 - OKYO Pharma Ltd (0001849296) (Issuer)
• 76d
  SEC Form 4 filed by Director Brancaccio John P

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 76d
  SEC Form 4 filed by Director Denoyer Bernard

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 76d
  SEC Form 4 filed by Chief Financial Officer Shah Keeren Rameshchandra

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 76d
  SEC Form 4 filed by Director Simon Willy Jules

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 76d
  Director Cerrone Gabriele M was granted 300,000 shares (SEC Form 4)

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 84d
  SEC Form 3 filed by new insider Denoyer Bernard

  3 - OKYO Pharma Ltd (0001849296) (Issuer)
• 85d
  New insider Simon Willy Jules claimed ownership of 15,383 shares (SEC Form 3)

  3 - OKYO Pharma Ltd (0001849296) (Issuer)
• 85d
  New insider Brancaccio John P claimed ownership of 30,201 shares (SEC Form 3)

  3 - OKYO Pharma Ltd (0001849296) (Issuer)
• 95d
  New insider Shah Keeren Rameshchandra claimed ownership of 16,667 shares (SEC Form 3)

  3 - OKYO Pharma Ltd (0001849296) (Issuer)
• 95d
  SEC Form 3 filed by new insider Dempsey Robert John

  3 - OKYO Pharma Ltd (0001849296) (Issuer)
• 160d
  SEC Form 3 filed by new insider Jacob Gary S

  3 - OKYO Pharma Ltd (0001849296) (Issuer)
• 160d
  SEC Form 3 filed by new insider Cerrone Gabriele M

  3 - OKYO Pharma Ltd (0001849296) (Issuer)
• 1029d
  Cerrone Gabriele M acquired $854,308 worth of Ordinary Shares (569,539 units at $1.50) (SEC Form 4)

  4 - OKYO Pharma Ltd (0001849296) (Issuer)
• 1063d
  Brancaccio John P bought $25,005 worth of Ordinary Shares (16,670 units at $1.50) (SEC Form 4)

  4 - OKYO Pharma Ltd (0001849296) (Issuer)